MENU
+Compare
ANTX
Stock ticker: NASDAQ
AS OF
Nov 13, 04:38 PM (EDT)
Price
$1.13
Change
-$0.05 (-4.24%)
Capitalization
30.88M

ANTX AN2 Therapeutics Forecast, Technical & Fundamental Analysis

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

ANTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ANTX with price predictions
Nov 12, 2025

ANTX in downward trend: price expected to drop as it breaks its higher Bollinger Band on October 27, 2025

ANTX broke above its upper Bollinger Band on October 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 31 similar instances where the stock broke above the upper band. In of the 31 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANTX as a result. In of 60 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANTX turned negative on November 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at .

ANTX moved below its 50-day moving average on October 31, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANTX crossed bearishly below the 50-day moving average on October 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ANTX entered a downward trend on November 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 43 cases where ANTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for ANTX moved above the 200-day moving average on October 15, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANTX advanced for three days, in of 194 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.449) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.723).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ANTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANTX is expected to report earnings to fall 29.03% to -21 cents per share on April 01

AN2 Therapeutics ANTX Stock Earnings Reports
Q4'25
Est.
$-0.22
Q3'25
Est.
$-0.31
Q2'25
Beat
by $0.10
Q1'25
Missed
by $0.10
Q4'24
Beat
by $0.02
The last earnings report on November 12 showed earnings per share of -31 cents, beating the estimate of -31 cents. With 37.84K shares outstanding, the current market capitalization sits at 30.88M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Managed Health Care
Address
1800 El Camino Real
Phone
+1 650 331-9090
Employees
41
Web
https://www.an2therapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IRS15.790.38
+2.47%
IRSA Inversiones Y Representaciones S.A
FHTX4.530.09
+2.03%
Foghorn Therapeutics
ATAT40.490.10
+0.24%
Atour Lifestyle Holdings Limited
MCK840.75-15.69
-1.83%
McKesson Corp
TBHC1.38-0.05
-3.50%
THE BRAND HOUSE COLLECTIVE INC

ANTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANTX has been loosely correlated with ROIV. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ANTX jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
-1.67%
ROIV - ANTX
34%
Loosely correlated
+2.01%
PASG - ANTX
32%
Poorly correlated
+21.82%
VYGR - ANTX
28%
Poorly correlated
-0.23%
PHAR - ANTX
28%
Poorly correlated
+8.61%
IONS - ANTX
27%
Poorly correlated
+0.30%
More